China Issues Guidelines for Medical Advertisement Identification, Clarifies Scenarios and Regulations
The State Administration for Market Regulation (SAMR), in collaboration with the National Health Commission (NHC)...
The State Administration for Market Regulation (SAMR), in collaboration with the National Health Commission (NHC)...
The U.S. Food and Drug Administration (FDA) announced the launch of “FDA PreCheck” on August...
China’s National Healthcare Security Administration (NHSA) released the preliminary formal review results for the 2025...
The Drug Administration of the Macao Special Administrative Region (SAR) of China has announced the...
The National Healthcare Security Administration (NHSA) has released Q&As on the medical institutions’ volumes filing...
On August 6, 2025, seven Shanghai-based authorities jointly issued a notice titled “Several Measures on...
The U.S. Food and Drug Administration (FDA) is implementing new safety measures for opioid pain...
China’s National Healthcare Security Administration (NHSA) has issued the “Interim Administrative Rules for Instant Settlement...
On July 31, 2025, China’s National Medical Products Administration (NMPA) commenced soliciting public comments on...
On July 28, 2025, China’s National Medical Products Administration (NMPA), the Ministry of Public Security,...
China’s National Medical Products Administration (NMPA) has approved the switch of ambroxol hydrochloride oral drops...
The National Healthcare Security Administration (NHSA) held a press conference today on the “High-Quality Completion...
On July 22, 2025, China’s National Health Commission (NHC) issued the “Work Plan for Integrated...
China’s Center for Drug Evaluation (CDE) is currently seeking public feedback on the 96th batch...
The Hebei provincial healthcare security administration has issued the “Notice on Improving the Separate Payment...
Beijing-based Konruns Pharmaceutical Co., Ltd. (SHA: 603590) announced on Wednesday that China’s Center for Drug...
China’s National Medical Products Administration (NMPA) has released the 94th batch of reference drugs for...
The National Healthcare Security Administration (NHSA) this week released its national medical and healthcare development...
The National Healthcare Security Administration (NHSA) this week issued the finalized “2025 National Basic Medical...
The National Medical Products Administration (NMPA) this week released a revised draft proposal for the...